Published in Usp Fiziol Nauk on May 06, 1997
[Significance of cardiac cannabinoid receptors in regulation of cardiac rhythm, myocardial contractility, and electrophysiologic processes in heart]. Izv Akad Nauk Ser Biol (2007) 0.99
Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism. Bull Exp Biol Med (2002) 0.85
Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart. Bull Exp Biol Med (2005) 0.85
Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion. Bull Exp Biol Med (2001) 0.83
Activation of kappa-opioid receptor as a method for prevention of ischemic and reperfusion arrhythmias: role of protein kinase C and K(ATP) channels. Bull Exp Biol Med (2007) 0.82
[Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors]. Eksp Klin Farmakol (2002) 0.82
[Plasma beta-endorphin and stress hormones in stress and adaptation]. Biull Eksp Biol Med (1987) 0.80
[Cardioprotective and antiarrhythmic properties of Rhodiolae roseae preparations]. Eksp Klin Farmakol (2007) 0.80
[Neuroprotective effect of ischemic postconditioning and remote preconditioning. Prospective of clinical use]. Angiol Sosud Khir (2012) 0.80
[Cardioprotective effect of remote ischemic preconditioning]. Angiol Sosud Khir (2009) 0.80
[Peripheral effects of ligands of ORL1 receptors]. Eksp Klin Farmakol (2004) 0.80
Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress. Life Sci (1999) 0.79
[Reactive oxygen species are triggers and mediators of an increase in cardiac tolerance to impact of ischemia-reperfusion]. Ross Fiziol Zh Im I M Sechenova (2015) 0.79
Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis. Bull Exp Biol Med (2002) 0.78
Cardioprotective effect of kappa1-opioid receptor activation and role of cAMP in its realization. Bull Exp Biol Med (2007) 0.78
[Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors]. Ross Fiziol Zh Im I M Sechenova (2002) 0.78
[The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress]. Eksp Klin Farmakol (1995) 0.78
Role of Intracellular Calcium and Cyclic Nucleotides in Realization of Cardioprotective Effects of δ(1)- and κ(1)-Opioid Receptor Agonists. Bull Exp Biol Med (2009) 0.78
[Delta-opioid receptor agonists prevent the irreversible damage of cardiomyocytes in ischemized-reperfused isolated rat heart]. Eksp Klin Farmakol (2005) 0.77
[The role of sarcolemmal and mitochondrial K(ATP)-channels in realization of the cardioprotection and antiarrhythmic effect of different regimens of hypobaric adaptation]. Ross Fiziol Zh Im I M Sechenova (2009) 0.77
Opioid receptors and heart resistance to arrhythmogenic factors. Bull Exp Biol Med (2004) 0.77
[Problem of end-effector of ischemic postconditioning of the heart]. Ross Fiziol Zh Im I M Sechenova (2013) 0.77
Negative inotropic and chronotropic effects of delta-opioid receptor antagonists are mediated via non-opioid receptors. Bull Exp Biol Med (2006) 0.77
Functional state of myocardial mitochondria in ischemia reperfusion of the heart in rats adapted to hypoxia. Bull Exp Biol Med (2014) 0.77
[Participation of K(ATP)-channels in cardioprotective effect of mu-opioid receptor agonists in acute ischemia and reperfusion of the isolated heart]. Eksp Klin Farmakol (2001) 0.77
[Role of kappa1 opioid receptors and cAMP in regulation of cardiac tolerance to ischemia and reperfusion]. Izv Akad Nauk Ser Biol (2008) 0.77
[Do endogenous ligands of peripheral mu- and delta-opiate receptors mediate anti-arrhythmic and cardioprotective effects of Rhodiola rosea extract?]. Biull Eksp Biol Med (1997) 0.77
[Antiarrhythmic effect of the antiopioid peptide nociceptin and its effect on fast Na+-channels in cardiomyocytes]. Biull Eksp Biol Med (1998) 0.77
Effect of stress adaptation on cyclic nucleotide content in myocardial tissue during acute ischemia/reperfusion. Bull Exp Biol Med (2008) 0.77
[Role of delta opioid receptors and their ligands in the development of adaptive heart protection against arrhythmogenesis]. Ross Fiziol Zh Im I M Sechenova (2001) 0.77
[The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea]. Eksp Klin Farmakol (1997) 0.77
[Hypoxic preconditioning of stem cells as a new approach to increase the efficacy of cell therapy for myocardial infarction]. Vestn Ross Akad Med Nauk (2013) 0.77
[The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands]. Eksp Klin Farmakol (2000) 0.76
Cardiac contractility after transplantation of autologous mononuclear bone marrow cells in patients with myocardial infarction. Bull Exp Biol Med (2006) 0.76
[Cognitive dysfunction and brain perfusion in patients with arterial hypertension: possibilities of pharmacological therapy]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.76
Cardioprotective effect of trimetazidine during thrombolytic therapy in patients with acute myocardial infarction. Bull Exp Biol Med (2002) 0.76
[Effect of cold stress on the contractile activity, carbohydrate and energy metabolism in the isolated rat heart]. Patol Fiziol Eksp Ter (1997) 0.76
[Effect of a Rhodiolae rosea extract on the level of inducible HSP-70 in the myocardium under stress]. Biull Eksp Biol Med (1996) 0.76
[Role of kappa-opioid receptors in the regulation of cardiac resistance to arrhythmogenic effects of ischemia and reperfusion]. Ross Fiziol Zh Im I M Sechenova (2006) 0.76
[Anti-arrhythmia effects of enkephalinase inhibitors]. Eksp Klin Farmakol (2001) 0.76
[Signaling mechanism of neuroprotective effect of ischemic preconditioning of brain]. Patol Fiziol Eksp Ter (2013) 0.76
[Specificity of the anti-arrhythmic effect of kappa1-opioid receptor agonists]. Eksp Klin Farmakol (2001) 0.76
Stimulation of mu and delta-Opiate Receptors and Tolerance of Isolated Heart to Oxidative Stress: the Role of NO-Synthase. Biochemistry (Mosc) (2001) 0.76
[Trigger mechanism of adaptive phenomenon of ischemic heart postconditioning]. Ross Fiziol Zh Im I M Sechenova (2012) 0.76
[Role of heat shock proteins, aldose reductase, Bcl-2 protein and microRNA in the mechanism of delayed preconditioning of heart]. Ross Fiziol Zh Im I M Sechenova (2010) 0.76
[Ischemic postconditioning of the heart. Receptor mechanisms and possibility of clinical use]. Kardiologiia (2010) 0.76
Receptor specificity of the antiarrhythmic effect produced by opioid peptides Dalargin and DADLE during myocardial reperfusion. Bull Exp Biol Med (2002) 0.76
[Effect of the acute exposure to cold on the heart muscle]. Ross Fiziol Zh Im I M Sechenova (1997) 0.76
Cardioprotective Activity of Ganoderma lucidum Extract during Total Ischemia and Reperfusion of Isolated Heart. Bull Exp Biol Med (2015) 0.75
[Neuroprotective and cardioprotective effects of hypothermic preconditioning]. Patol Fiziol Eksp Ter (2012) 0.75
[Anti-arrhythmic effect of phytoadaptogens]. Eksp Klin Farmakol (2000) 0.75
[Role of kappa1 opioid receptors and cAMP in regulation of cardiac tolerance to ischemia and reperfusion]. Izv Akad Nauk Ser Biol (2008) 0.75
[Antiarrhythmic and cardioprotective effect of stimulation of delta1-opiate receptors in myocardial ischemia and reperfusion]. Patol Fiziol Eksp Ter (2004) 0.75
[Dependence of the pump function of the isolated rat heart on the functional activity of sigma receptors during reperfusion]. Ross Fiziol Zh Im I M Sechenova (1999) 0.75
[Significance of opioid receptors in regulation of cardiac tolerance in pathogenic impact of long-term ischemia-reperfusion in vivo]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75
[The role of delta-1 opiate receptors in regulation of contractility in isolated rat heart during normal oxygenation and ischemia-reperfusion]. Izv Akad Nauk Ser Biol (2004) 0.75
Participation of central kappa-opioid receptor in arrhythmogenesis. Life Sci (1997) 0.75
[Perspective of creation of drugs on basis of opioids increasing cardiac tolerance to pathogenic impact of ischemia reperfusion]. Eksp Klin Farmakol (2012) 0.75
[Comparative study of the antiarrhythmic activity of mu- and delta-opioid receptor agonists during acute cardiac ischemia and reperfusion models in rats]. Eksp Klin Farmakol (2006) 0.75
[Effect of stimulation of mu-opiate receptors on contractility of the isolated heart in normal oxygenation and during ischemia-reperfusion]. Ross Fiziol Zh Im I M Sechenova (2001) 0.75
[Delta-opioid receptor activation prevents appearance of irreversible damages of cardiomyocytes and exacerbates myocardial contractility dysfunction during ischemia and reperfusion]. Patol Fiziol Eksp Ter (2007) 0.75
[Blood-brain barrier permeability for the ligands of opioid receptors]. Eksp Klin Farmakol (2002) 0.75
Participation of central and peripheral kappa 1 and kappa 2 opioid receptors in arrhythmogenesis. Clin Exp Pharmacol Physiol (1999) 0.75
[mu-Opiate receptor activation and increase in heart resistance to ischemic and reperfusion injury]. Ross Fiziol Zh Im I M Sechenova (1998) 0.75
[Ligands of opioid and sigma receptors and correction of cardiac electrical instability in post-infarction cardiosclerosis]. Eksp Klin Farmakol (2001) 0.75
[Intracellular mechanisms of opioidergic regulation of the myocardial function during normoxia and postischemic reperfusion]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75
[Contribution of the endogenous opioid system to regulation of heart resistance to the arrhythmogenic effect of short-term ischemia and reperfusio]. Izv Akad Nauk Ser Biol (2005) 0.75
[The effect of stimulation of cardiac delta1-opioid receptors on the resistance of isolated heart to the action of ischemia and reperfusion]. Eksp Klin Farmakol (2006) 0.75
[The antiarrhythmic effect of (-)-U-50,488 in rats with acute ischemia and reperfusion of heart is mediated by kappa1-opioid receptor activation]. Eksp Klin Farmakol (2005) 0.75